Patent Law | Expert Legal Commentary

March 4, 2010

Forest Group v. Bon Tool: Upping the Incentives for False Marking Claims

The Forest Group, Inc. v. Bon Tool Co.

By Jeffrey J. Zuber of Zuber & Taillieu and Yuri Mikulka

The Federal Circuit has determined that the maximum fine for violation of the federal false marking statute should be applied on a per article basis, rather than the “per decision” basis applied by a majority of district courts in the past. In The Forest Group, Inc. v. Bon Tool Co., 590 F.3d 1295 (Fed. Cir. 2009), the Federal Circuit explicitly overruled one such district court interpretation, holding that only a “per article” application of the penalty would give the false marking statute its intended teeth and encourage private enforcement of the statute. While the decision does provide strong disincentives to false marking, it also opens the door to “marking trolls” – opportunistic plaintiffs looking to make money off false marking claims.

About the Author

Jeffrey J. Zuber is a Partner of Zuber & Taillieu, focusing on intellectual property litigation and arbitration.

Image Credit: ©iStockphoto.com/saluha

E-mail Email this Article
Print Printable Version (in new window)
View a PDF of the judicial opinion

Connect on Linkedin®

Jeffrey J. Zuber

Companies Mentioned

Bon Tool Company

Cibon Industrial

Forest Group, Inc.

Shanghai Honest Tool Co., Inc.

More Updates

Patent Law Updates

Companies Mentioned

Patent Law

The following companies are mentioned in Patent Law Updates:

Boston Scientific Corp.

Microsoft Corp.

Boston Scientific Scimed, Inc.

U.S. Patent and Trademark Office

Stryker Corp.

Samsung Electronics America, Inc.

Cordis Corp.

Target Corp.

Sears Holding Corp.

Kohl’s Department Stores, Inc.

K-Mart Corp.

J.C. Penney Company, Inc.

Audiovox Communications Corp.

Glamourmom LLC

McKesson Information Solutions, Inc.

Federated Department Stores

Bridge Medical, Inc.

Elizabeth Lange LLC d.b.a. Liz Lange Maternity

United States Patent and Trademark Office

Smithkline Beecham Corp. (d.b.a. GlaxoSmithKline, plc.)

SmithKline Beecham PLC

HT Window Fashion Corp.

SmithKline Beecham Corp. d.b.a GlaxoSmithKline

Scimed Life Systems Inc.

Ortho-McNeil Pharmaceutical, Inc.

Glaxo Group Limited d.b.a. GlaxoSmithKline

Mylan Pharmaceutical, Inc.

Ranbaxy, Inc.

Teva Pharmaceuticals USA, Inc.

Mylan Laboratories, Inc.

Nokia, Inc.

Stryker Sales Corp.

Stryker Orthopaedics

Howmedica Osteonics Corp.

Acumed, LLC

Quanta Computer, Inc.

Sanyo North America Corp.

LG Electronics, Inc.

Smith & Nephew, Inc.

Cohesive Technologies, Inc.

Waters Corp.

Swisa, Inc.

Egyptian Goddess, Inc.

Motorola, Inc.

Dror Swisa

Johnson & Johnson, Inc.

Wal-Mart Stores, Inc.

AMI Semiconductor, Inc.

Innostream, Inc.

InfoSpace, Inc.

Additional Resources

Patent Law